Liver Resection in Hepatitis B-Related Hepatocellular Carcinoma: Clinical Outcomes and Safety in Overweight and Obese Patients

被引:17
|
作者
Wang, Haiqing [1 ]
Yang, Jian [1 ]
Zhang, Xiaowu [1 ]
Yan, Lunan [1 ]
Yang, Jiayin [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
BODY-MASS-INDEX; PERIOPERATIVE OUTCOMES; RESOURCE UTILIZATION; CHINESE ADULTS; COMPLICATIONS; SURGERY; HEPATECTOMY; CIRRHOSIS; IMPACT; CANCER;
D O I
10.1371/journal.pone.0099281
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective and Background: Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample. Methods: In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI >= 28), overweight(BMI: 24.0-27.9), normal weight(BMI: 18.5-23.9) and underweight(BMI<18.5). The Dindo-Clavien classification system was used for grading complications. Clinical characteristics and operative outcomes were compared among the four groups. Risk factors for postoperative complications were evaluated by multivariate analysis. Results: According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort. Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001). Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications. However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%, P<0.001,11.0% vs 2.5%, P = 0.001). Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications. Conclusions: Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Liver resection in hepatitis B related-hepatocellular carcinoma: Clinical outcomes and safety in elderly patients
    Wang, Hai-Qing
    Yang, Jian
    Yan, Lu-Nan
    Zhang, Xiao-Wu
    Yang, Jia-Yin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (21) : 6620 - 6625
  • [2] Liver resection in hepatitis B related-hepatocellular carcinoma: Clinical outcomes and safety in elderly patients
    Hai-Qing Wang
    Jian Yang
    Lu-Nan Yan
    Xiao-Wu Zhang
    Jia-Yin Yang
    World Journal of Gastroenterology, 2014, (21) : 6620 - 6625
  • [3] Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma
    Chong, C. C. N.
    Lai, P. B. S.
    BRITISH JOURNAL OF SURGERY, 2013, 100 (06) : 724 - 725
  • [4] Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma
    Jung, Yoon Bin
    Yoo, Jeong Eun
    Han, Dai Hoon
    Kim, Kyung Sik
    Choi, Jin Sub
    Kim, Do Young
    Park, Young Nyun
    Choi, Gi Hong
    HPB, 2021, 23 (07) : 1113 - 1122
  • [5] the prevention of hepatitis B-related hepatocellular carcinoma
    Lin, C. -L.
    Kao, J. -H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 5 - 14
  • [6] Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis
    Ren, Meixin
    Li, Juan
    Xue, Ran
    Wang, Zhongying
    Li, Shengli
    Meng, Qinghua
    MEDICINE, 2019, 98 (19)
  • [7] Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes
    Block, Peter D.
    Shinn, Brianna
    Kim, Jin Hyang
    Hann, Hie-Won
    HEPATIC ONCOLOGY, 2021, 8 (01)
  • [8] Survival of Patients with Hepatitis B-Related Hepatocellular Carcinoma with Concomitant Metabolic Associated Fatty Liver Disease
    You, Yajing
    Yang, Tao
    Wei, Shuhang
    Liu, Zongxin
    Liu, Chenxi
    Shen, Zijian
    Yang, Yinuo
    Feng, Yuemin
    Yao, Ping
    Zhu, Qiang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2283 - 2293
  • [9] Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection
    Choi, Won-Mook
    Lee, Jeong-Hoon
    Ahn, Hongkeun
    Cho, Hyeki
    Cho, Young Youn
    Lee, Minjong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Dong Hyeon
    Lee, Yun Bin
    Cho, Eun Ju
    Yu, Su Jong
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Suh, Kyung-Suk
    Kim, Chung Yong
    Lee, Hyo-Suk
    LIVER INTERNATIONAL, 2015, 35 (08) : 1992 - 2000
  • [10] Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
    Yu, MW
    Chang, HC
    Chen, PJ
    Liu, CJ
    Liaw, YF
    Lin, SM
    Lee, SD
    Lin, SC
    Lin, CL
    Chen, CJ
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (05) : 1008 - 1015